Combining Advanced Wound Care Modalities for Improved Outcomes: Integrating NPWT, ORC Collagen and Hybrid Drapes
FACULTY
Emily Greenstein, ARPN, CNP, CWON-AP, FACCWS
Essentia Health
Fargo, North Dakota
Catherine Milne, MSN, APRN, CWOCN, BC-ANP
Connecticut Clinical Nursing Associates
Bristol, Connecticut
Dot Weir, RN, CWON, CWS
Saratoga Hospital Wound Healing
Gansevoort, NY
PROVIDER STATEMENT
Provided by HMP Education, an HMP Global Company.
INTENDED LEARNERS
This activity is designed for physicians, nurse practitioners, physician assistants, nurses, and podiatrists across all practice settings involved in the prevention, treatment, and management of patients with wounds.
LEARNING OBJECTIVES
After participating in this activity, learners should be better able to:
- Evaluate the science, evidence and wound healing efficacy of oxidized regenerated cellulose (ORC)/collagen
- Explain the science and clinical significance of negative pressure wound therapy
- Review wound types that are prime candidates for the use of silicone-hybrid drapes with negative pressure wound therapy (NPWT) and examine the impact of these drapes on periwound skin protection, pain management and wound healing
- Explore, via illustrative case studies, clinical outcomes from the combines use of NPWT, ORC collagen and hybrid drapes
ACTIVITY OVERVIEW
This on-demand webcast is available with synchronized slides and video/audio.
To be eligible for documentation of credit for each session attended, learners must participate in the activity complete 4-question post-test with a minimum score of 75% and complete the activity evaluation. Participants who complete the evaluation online within active dates of the training will receive documentation of credit. Your certificate may not load if you are accessing it from a smartphone, or settings of your browser do not allow for a new tab/window to open.
Once a certificate has been claimed, physicians and pharmacists may elect for credits to be submitted on their behalf to their boards via additional fields that will appear within the Claim Certificate page. Credits must be submitted through this process to be reported to the American Board of Surgery and the National Association of Boards of Pharmacy.
Release Date: November 20, 2023
Expiration Date: November 30, 2024
Estimated Time to Complete: 1.0 hour
There is no fee associated with this activity.
HARDWARE/SOFTWARE REQUIREMENTS
The activity is best supported via a computer or device with current versions of the following browsers: Mozilla Firefox, Google Chrome, or Safari. A PDF reader is required for print publications.
CONTINUING EDUCATION
In support of improving patient care, HMP Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Note: This statement is not an indication of approved credits. Please see below for full accreditation details, including credit types and totals, for this activity.
PHYSICIANS
HMP Education designates this internet enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
NURSES
This continuing nursing education internet enduring activity awards 1.0 contact hour. Provider approved by the California Board of Registered Nursing, Provider #13255 for 1.0 contact hour.
NURSE PRACTITIONERS
American Academy of Nurse Practitioners National Certification Program accepts AMA PRA Category 1 CreditTM from organizations accredited by the ACCME.
PHYSICIAN ASSOCIATES / ASSISTANTS
HMP Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with the AAPA CME Criteria. This internet enduring activity is designated for 1.0 AAPA Category 1 credit. Approval is valid until November 30, 2024. PAs should only claim credit commensurate with the extent of their participation.
DIETITIANS
PODIATRISTS
HMP Education is approved by the Council on Podiatric Medical Education as a provider of continuing education in podiatric medicine. HMP Education has approved this internet enduring activity for a maximum of 1.0 continuing education contact hour.
INTERNATIONAL RECOGNITION
The following Countries, Regions, and Accrediting Bodies accept, or have reciprocity or mutual recognition of credits with the AMA/ACCME. Please contact the accrediting body to find out more information on submitting or converting your credits.
- Bavarian Chamber of Physicians (Germany)
- Bulgarian Union of Scientific Medical Societies (Bulgaria)
- Canadian Medical Association (Canada)
- Canadian Nurses Association (Canada)
- EBAC® (European Board for Accreditation of Continuing Education for Health Professionals)
- Federation of Royal Colleges of Physicians (UK)
- French National Medical Council (France)
- Italian Federation of Scientific Medical Societies (Italy)
- National CME Commission of the Italian Ministry of Health (Italy)
- Spanish Accreditation Council for CME (Spain)
- UEMS-EACCME® (European Union of Medical Specialists)
USE OF PROPRIETARY NAMES
This continuing medical education activity may include device or medicine brand names for participant clarity purposes only, due to the presence of different branded versions of the same product. No product promotion or recommendation should be inferred.
UNAPPROVED AND/OR INVESTIGATIONAL USES OF DRUGS AND DEVICES
This activity may contain information about experimental and other uses of drugs or devices that are not currently approved by the European Medicines Agency (EMA) of the European Union or the Food and Drug Administration (FDA) of the United States. Participants are strongly encouraged to consult approved product labeling for any drug or device mentioned in this activity before use. The opinions expressed during this activity are the opinions of the respective authors, presenters or moderators and do not necessarily reflect the opinions of HMP Education.
DISCLAIMERS
The material presented and related discussions are not intended to be medical advice, and the presentation or discussion of such material is not intended to create and does not establish a provider-patient relationship. Medical advice of any nature should be sought from an individual’s own provider.
The opinions expressed in this educational activity are those of the faculty and are not attributable to HMP Global or any of its subsidiaries or affiliates. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
HMP Education is an independent provider of continuing medical education. HMP Education has no proprietary or financial interest in medical or healthcare products over which the FDA (USA) or EMA (EU) has regulatory authority.
In accordance with our disclosure policies, HMP Education is committed to ensuring balance, independence, objectivity, and scientific rigor for all accredited continuing education. These policies include assigning relevance to, and mitigating, all perceived or real relevant financial relationship (conflicts of interest) between any individual with control over the content and any ineligible company (commercial interest) as defined by the ACCME and CPME.
Any individual with control over accredited content, including planner, faculty, and reviewer, is required to globally disclose:
- Individual relationship(s) or lack thereof, and its nature, with any/all ineligible company, and;
- Any investigational, off-label, or non-FDA approved content or discussion
HMP Education has reviewed these disclosures, assigned relevance based on the relationship and scope of content, and identified those with the potential to compromise the goals and educational integrity of the education. Relevant relationships, or lack thereof, are shared with the learner.
Education has been independently peer-reviewed to validate content, mitigate identified financial relationships (conflicts of interest), and ensure:
- All recommendations involving clinical medicine is based on evidence that is accepted within the medical profession as adequate justification for their indications and contraindications in the care of patients.
- All scientific research referred to, reported, or used in accredited continuing education in support or justification of a patient care recommendation conforms to the generally accepted standards of experimental design, data collection, and analysis.
- Content is appropriate, fair and balanced, unbiased, referenced, and non-promotional.
All relevant financial relationships have been mitigated.
FACULTY
The faculty has reported the following:
Emily Greenstein, ARPN, CNP, CWON-AP, FACCWS: 3M/KCI: Advisory Board: 3M/KCI, Coloplast; Consultant: 3M/KCI, Coloplast, Smith and Nephew, URGO STEDMEN; Speaker’s Bureau: 3M/KCI, Coloplast, Smith and Nephew, URGO STEDMEN
Catherine T. Milne, MSN, APRN, ANP/ACNS-BC, CWOCN-AP: Advisory Board: Medline Post-Acute Care, CARS- Coalition for At-Risk-Skin Co-Chair – Volunteer position; Post-Acute Wound and Skin Integrity Council (PAWSIC) – Volunteer position / Speaker's Bureau: 3M Health Care, Medical Solutions Division, Aroa, Convatec, Medline, Musculoskeletal Transplant Foundation, Smith & Nephew, vTail, WoundReference, Inc.
Dot Weir, RN, CWON, CWS: Advisory Board: Molnlycke Health Care; Moleculight; Smith & Nephew; Urgo Medical North America / Consultant: 3M; Misonix; Molnlycke Health Care; Pfizer, Inc. / Speaker's Bureau: 3M; Lohmann & Rauscher; Medline Industries, Inc.; Molnlycke Health Care; Organogenesis, Inc.; Smith & Nephew; Urgo Medical North America
CLINICAL REVIEWER
Daniel G. Federman, MD
Professor of Medicine, Yale University School of Medicine
Yale University School of Medicine
Newtown, Connecticut
Dr. Daniel Federman has no relevant disclosures.
PLANNING COMMITTEE
HMP Education planners and staff include Samantha Joy, Adriana LeBer, Tiffney Oliver, Randy Robbin, and Andrea Zimmerman.
No HMP Education planner or staff has disclosed a relevant financial relationship with any ineligible company (commercial interest).
ADA STATEMENT
HMP Education complies with the legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. If any participant in this educational activity needs accommodation(s), please submit a request to contact the support team.
PRIVACY POLICY
HMP Education protects the privacy of personal and other information regarding participants, educational partners, and joint providers. HMP Education and our joint providers will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency. HMP Education maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.
Copyright © 2024 by HMP Education. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from HMP Education.
COMMERCIAL SUPPORT
This activity is supported by an independent educational grant from 3M Health Care, Medical Solutions Division.
CONTACT US
For immediate assistance, please explore our HMP Education Help Center or chat with our Virtual CE Assistant who can answer most common questions related to claiming credits and the HMP Education website. If you have a question or grievance that cannot be answered by our Virtual CE assistant and Help Center, please submit a request to contact the support team. Our accreditation and compliance team will respond to your inquiry within 1 business day.